Seeking AlphaCutting Edge Gene Therapies: Beta-Thalassemia Breakthroughs (Part I)Seeking AlphaThere have been many gene therapy companies which have arisen over the past decade to treat beta-thalassemia. This devastating illness results in very high li… Continue reading
|
Growth Insights on the Global CRISPR/Cas9 Tools Market 2017: A Disruptive Technology – Gene-editing Tools for …
Business Wire (press release) Since its inception, CRISPR has gained strong traction from the global research community because of its huge potential in diverse applications. Considering CRISPR’s disruptive and game-changing applications, a number of large and small participants … Vertex Pharma (VRTX) CRISPR Therapeutics (CRSP) to Co-Develop and Co-Commercialize CTX001 as CRISPR …StreetInsider.com Crispr Therapeutics (CRSP) Rating Reiterated by CannThe Lincolnian Online Crispr Therapeutics (CRSP) Earning Somewhat Positive News Coverage, Report ShowsWeek Herald |
Business Insider |
Paralysed rats walk again after breakthrough surgery using stem cells from a human’s mouth
Business Insider Seeing a rat scurry by would send many people running away screaming, but researchers at Israel’s Technion institute of technology were joyful when they saw one particular rodent walking. The rat, once paralysed with a completely severed spinal cord … |
Sanvada Tech News (blog) |
Biotech Companies Are Preparing the First CRISPR Test on Humans
Sanvada Tech News (blog) This technology for gene-editing treatment has been in the works for quite some time, but could finally come to market due to a company known as CRISPR Therapeutics. The company says it’s ready to test its findings on people, and as such, it has asked … |
|
Vertex Pharma (VRTX) CRISPR Therapeutics (CRSP) to Co-Develop and Co-Commercialize CTX001 as CRISPR …
StreetInsider.com Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and CRISPR Therapeutics AG (NASDAQ: CRSP) today announced that the companies will co-develop and co-commercialize CTX001, an investigational gene editing treatment, as part of the companies’ previously … Crispr Therapeutics (CRSP) Rating Reiterated by CannThe Lincolnian Online |